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MIR494 reduces renal cancer cell survival
coinciding with increased lipid droplets
and mitochondrial changes
Punashi Dutta1, Edward Haller2, Arielle Sharp1 and Meera Nanjundan1*

Abstract
Background: miRNAs can regulate cellular survival in various cancer cell types. Recent evidence implicates the
formation of lipid droplets as a hallmark event during apoptotic cell death response. It is presently unknown
whether MIR494, located at 14q32 which is deleted in renal cancers, reduces cell survival in renal cancer cells and
if this process is accompanied by changes in the number of lipid droplets.
Methods: 769-P renal carcinoma cells were utilized for this study. Control or MIR494 mimic was expressed in these
cells following which cell viability (via crystal violet) and apoptotic cell numbers (via Annexin V/PI staining) were
assessed. By western blotting, MIR494 cellular responses were validated using MIR494 antagomir and Argonaute 2
siRNA. Transmission electron microscopy (TEM) was performed in MIR494-transfected 769-P cells to identify
ultrastructural changes. LipidTOX green neutral lipid staining and cholesterol measurements were conducted to
assess accumulation of lipids droplets and total cholesterol levels, respectively, in MIR494 expressing 769-P cells.
Indirect immunofluorescence and western analyses were also performed to examine changes in mitochondria
organization. Co-transfection of MIR494 mimic with siRNA targeting LC3B and ATG7 was conducted to assess their
contribution to formation of lipid droplets in MIR494-expressing cells.
Results: MIR494 expression reduces viability of 769-P renal cancer cells; this was accompanied by increased cleaved
PARP (an apoptotic marker) and LC3B protein. Further, expression of MIR494 increased LC3B mRNA levels and LC3B
promoter activity (2.01-fold; 50 % increase). Interestingly, expression of MIR494 markedly increased multilamellar
bodies and lipid droplets (by TEM and validated by LipidTOX immunostaining) while reducing total cholesterol
levels. Via immunocytochemistry, we observed increased LC3B-associated endogenous punctae upon MIR494
expression. In contrast to ATG7 siRNA, knockdown of LC3B reduced the numbers of lipid droplets in MIR494expressing cells. Our results also identified that MIR494 expression altered the organization of mitochondria which
was accompanied by co-localization with LC3B punctae, decreased PINK1 protein, and altered Drp1 intracellular
distribution.
Conclusion: Collectively, our findings indicate that MIR494 reduces cell survival in 769-P renal cancer cells which is
accompanied by increased lipid droplet formation (which occurs in a LC3B-dependent manner) and mitochondrial
changes.
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Background
Activation of cell death pathways including apoptosis,
autophagy, and necrosis can oppose cell survival [1].
Since such signaling pathways can be regulated in a
miRNA-dependent manner, miRNA expression patterns
may provide insight into response to chemotherapeutic
agents [2, 3]. Interestingly, apoptosis has recently been
shown to be associated with the formation of lipid
droplets (LDs) [4, 5]. These subcellular organelles are
comprised of neutral lipids (i.e., triacylglycerol and
cholesterol esters) that are membrane bound by phospholipids [6]. There are a number of miRNAs with
emerging roles in regulating lipid metabolism by targeting genes in lipid pathways [7–13]. Kidney cancer is described as a metabolic disease in which the renal clear
cell subtype is characterized by increased lipid droplets
[14]; it has yet to be investigated whether miRNAs contribute to metabolic dysregulation in this disease. Interestingly, in this disease, the 14q32 locus is deleted and
contains one of the largest miRNA clusters (54 miRNAs) in the human genome and is located within the
DLK1-DIO3 region [15]. Amongst the miRNAs located
at this region, MIR494, located at ch14:101029634 –
ch14:101029714, has thus far been already implicated
in altering epithelial-mesenchymal transition (EMT)
[16], senescence [17, 18], cell cycle arrest [19], and
apoptosis [20] in a few cancer cell types. Whether
MIR494 alters renal cancer cell survival and lipid droplet formation is presently unknown.
Herein, we demonstrate that expression of MIR494 in
the 769-P renal cancer cell line reduces cellular viability
coinciding with increased LC3B RNA and protein. We
noted increased lipid droplets in MIR494 expressing cells
(via TEM and cellular staining with LipidTOX) which was
dependent on LC3B protein expression. In addition,
MIR494 expression led to mitochondrial changes that involved changes in Drp1 localization and reduced PINK1
protein, molecules involved in altering mitochondrial
structural patterns. Collectively, these findings implicate
MIR494 expression in reducing renal cancer cell survival
accompanied by increased lipid droplet formation and
mitochondrial changes.
Methods
Ethics approval

No animal or human specimens were used in this study.
The cell lines used (as described below) are de-identified
and cannot be linked back to human subjects. The studies reported in this manuscript were submitted to the
IRB at the University of South Florida. They provided official assessment of Not Human Subjects Research Determination (IRB#: Pro00024882). The IRB Chairperson
is Dr. E Verena Jorgensen at the University of South
Florida Institutional Review Board.
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Cell lines

769-P renal carcinoma cells were obtained from ATCC
(Manassas, VA). Normal immortalized (LTAg/hTERT)
ovarian surface epithelial cells (T80) were kindly provided by Dr. Gordon Mills (MD Anderson Cancer Center, Houston, Texas). 769-P and T80 cells were cultured
in RPMI 1640 (Hyclone, Fisher Scientific, Pittsburgh,
PA) supplemented with 8 % FBS and penicillin/streptomycin. Cells were maintained in a 37 °C humidified incubator containing 95 % air and 5 % CO2. All cell lines
used in this study were authenticated by STR profiling
(Genetica DNA Laboratories Inc., Cincinnati, OH) and
mycoplasma tested as negative.
Preparation of As2O3 and cisplatin for T80 cell treatment

As previously described, As2O3 was dissolved in NaOH
followed by dilution with Nanopure water [21]. A stock
solution of 5 mM was prepared and used at a final concentration of 2, 5, 10, 25, or 50 μM (Sigma-Aldrich, St.
Louis, MO). Cisplatin (Calbiochem, #232120) was dissolved in phosphate-buffered saline (PBS) at a stock concentration of 6.7 mM and used at a final concentration of
100 μM. T80 cells were seeded at 250,000 cells/well in 6well plates. Following overnight adherence, they were
treated with the above mentioned doses of As2O3 for 18 h
and cisplatin for 12, 18, and 24 h.
miRNA and siRNA transfections

Cells were seeded at 250,000 cells/well in 6-well plates.
Following overnight adherence, they were transfected
with control MIR (mirVana miRNA mimic Negative
control 1, #4464058, Life Technologies, Grand Island,
NY) or MIR494 (mirVana miRNA mimic, hsa-miR-4943p, #4464066 (ID MC12409), Life Technologies, Grand
Island, NY) (final concentration of 200 pmol) using
Fugene HD (Promega, Madison, MI). Cells were recovered 24 h post-transfection. Protein lysates were harvested 96 h post-transfection.
For transfection of siRNA (Ago2, L-004639-00; ATG7,
L-020112-00; LC3B, L-012846-00; non-targeting ONTARGETplus control (D-001810-10-20), Dharmacon,
Lafayette, CO), in combination with miRNA [22], 769-P
cells were seeded at 750,000 cells/well. Following 24 h,
an initial round of siRNA treatment was performed
using a dose of 50 nM. Another round of siRNA transfection (50 nM) was performed on the following day.
Twenty-four hours later, cells were recovered and then reseeded at 250,000 cells/well. On the successive day, cells
were transfected with control MIR or MIR494 (200 pmol).
Cell lysates were harvested 72 h post-MIR transfection for
western analyses, immunofluorescence staining, or
annexin V-FITC/PI staining. For LipidTOX neutral lipid
staining, cells were re-seeded on glass coverslips following
two rounds of siRNA transfection, as described above.
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Protein harvest and western blotting

Cells were incubated in lysis buffer (1 % Triton X-100,
50 mM HEPES, 150 mM NaCl, 1 mM MgCl2, 1 mM
EGTA, 10 % glycerol, and protease inhibitor cocktail) for
1 h at 4 °C. Cell lysates were harvested by scraping and
centrifuged at 14,000 rpm for 10 min at 4 °C. Normalized
samples (using the BCA assay (Fisher Scientific, Pittsburgh, PA)) were run on SDS-PAGE gels and transferred
to polyvinylidene fluoride (PVDF) membranes for western
blotting. Bound antibody was detected using enhanced
chemiluminescence reagent followed by exposure to film.
Primary antibodies were used at the following dilutions
and obtained from the following sources: Ago2 rabbit
monoclonal (#2897, 1:500), caspase 2 mouse monoclonal (1:1000), caspase 3 rabbit monoclonal (1:1000),
caspase 8 mouse monoclonal (1:1000), and caspase 9
mouse monoclonal (1:1000) (Initiator caspases sampler
kit #12675), Drp1 rabbit monoclonal (#8570, 1:1000),
GAPDH rabbit monoclonal (#2118, 1:5000), LC3B
rabbit polyclonal (#2775, 1:1000), pan-actin rabbit polyclonal (#4968, 1:1000), PARP rabbit polyclonal (#9542,
1:1000), and PINK1 rabbit monoclonal (#6946, 1:500)
antibodies were obtained from Cell Signaling Technology (Danvers, MA). ATG7 rabbit polyclonal antibody
(PM039, 1:1000) was obtained from MBL International
Corporation (Woburn, MA).
RNA isolation and quantitative PCR

769-P cells were seeded at 250,000 cells/well and transfected with miRNA following overnight adherence.
Twenty-four hours post-transfection, cells were trypsinized and re-seeded at 250,000 cells/well and then at 96 h
post-transfection, total RNA isolation was then carried
out using the RNeasy Mini Kit from Qiagen (Valencia,
CA). Real-time PCR was performed using the One-Step
PCR Taqman Master Mix (Applied Biosystems, Grand
Island, NY). Probes/primers for LC3B were obtained from
Applied Biosystems (Assays-on-Demand (Hs00797944_s1)).
β-actin was used as the endogenous control. PCR cycle
conditions and analyses were performed as reported previously [21].
miRNA isolation and quantification

The mirVana miRNA isolation kit from Ambion (Grand
Island, NY) was utilized for total RNA isolation (according
to the manufacturer’s protocol). The RNA concentrations
were assessed using NANOdrop. The TaqMan miRNA
probe-based qRT–PCR reaction (Taqman MicroRNA
Assays, Applied Biosystems, Grand Island, NY) was performed in reaction buffer containing dNTPs and reverse
transcriptase enzyme (7 μl). The total reaction volume
was 15 μl (5 μl RNA and 3 μl probes/primers). The reaction conditions for RT were as follows: 30 min, 16 °C;
30 min, 42 °C; 5 min, 85 °C. The PCR reaction conditions
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were as follows: 10 min, 95 °C; 50 cycles (Denature: 15 s,
95 °C; Anneal: 60 s, 60 °C). The RNA concentration utilized was 500 μg/μl in 20 μl total reaction volume (TaqMan MicroRNA Assay, RT product, TaqMan Universal
PCR Master Mix). The relative miRNA levels were calculated using the comparative CT method. The probes/
primers utilized for the reverse transcription and PCR reactions for MIR494 were RT:002365, TM:002365 and for
RNU6B were RT:001093, TM:001093.
Cell viability assay

769-P cells were seeded at 250,000 cells/well in 6 well
plates. Transfection with MIR494 or control MIR was
performed as described above. Twenty-four hours posttransfection, cells were re-seeded into 96 well plates at
2500 or 5000 cells/well. At 120 h post-transfection,
media was removed and cells stained with crystal violet
for 15 min at room temperature. The cells were washed
with nanopure water and after overnight drying, Sorenson’s buffer was added, shaken for 2 h at room
temperature, and then read at 570 nm using a Biotek
plate reader.
Apoptosis assay

For assessment of apoptosis, annexin V-PI staining was
performed following manufacturer’s instructions (#PF032,
Calbiochem, San Diego, CA). Briefly, cells were seeded at
250,000 cells/well in 6-well plates. Following MIR494 or
control MIR transfections, both floating and adherent (by
trypsinization) cell populations were collected and pelleted 96 h post-miRNA transfection. Cell pellets were then
resuspended in PBS followed by the addition of annexin V
and PI, after which the samples were analyzed by flow
cytometry (Karoly Szekeres, College of Medicine, Flow
Cytometry Core, University of South Florida, Tampa,
Florida).
For ATG7 or LC3B siRNA, 769-P cells were seeded at
750,000 cells/well. Following overnight adherence, two
successive rounds of siRNA knockdown was performed
(50 nM). Twenty-four hours later, cells were recovered
and then re-seeded at 250,000 cells/well. On the successive day, cells were transfected with control MIR or
MIR494 (200 pmol). Seventy-two hours post-mimic
transfection, cells were processed for annexin V-PI staining as described above.
Indirect immunofluorescence

769-P cells were seeded at 250,000 cells/well. Following
overnight attachment, cells were transfected with control
MIR or MIR494 as described above. Twenty-four hours
post-transfection, cells were trypsinized and re-seeded on
glass coverslips at 150,000 cells/well. Ninety-six hours
post-transfection, cells were fixed using 4 % formaldehyde
for 30 min at room temperature (this method of fixation
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was used for AIF rabbit monoclonal antibody (Cell Signaling Technology, #5318, 1:400), cytochrome c mouse
monoclonal antibody (Cell Signaling Technology, #12963,
1:250), and Drp1 rabbit monoclonal antibody (Cell Signaling Technology, #8570, 1:50)), or fixation in 100 % cold
methanol for 15 min at −20 °C (for LC3B rabbit polyclonal
antibody, Cell Signaling Technology, #2775, 1:400 dilution). For experiments involving co-staining of LC3B and
cytochrome c, cells were first fixed with 4 % formaldehyde
for 15 min at room temperature followed by fixation in
100 % cold methanol for 15 min at −20 °C.
769-P cells were seeded onto glass coverslips at 1 million cells/well in 6-well plates. Cell were then fixed and
stained the following day with AIF rabbit monoclonal
antibody (Cell Signaling Technology, #5318, 1:400) or
COXIV monoclonal antibody (Cell Signaling Technology,
#4850, 1:250).
T80 cells were seeded at 500,000 cells/well in 6 well
plates onto glass coverslips. Twenty-four hours postseeding, treatment with cisplatin was initiated. Cells
were then fixed and stained with AIF rabbit monoclonal
antibody as described above.
The mitochondrial structural patterns were divided
into four categories: (1) tubular elongated, (2) tubular
shortened, (3) tubular shortened fragmented, and (4)
fragmented mitochondria. Cells were counted, assigned
to these four categories, LC3B punctae status recorded,
and quantified accordingly.
Co-localization of cytochrome c with Drp1 as well as
LC3B with cytochrome c were performed using Volocity
3D Imaging Software (version 6.3) from PerkinElmer
(Waltham, MA). Thresholds were set for individual channels and Pearson coefficients averaged for each set of replicates. Data analyzed for Fig. 5b and f are shown in
Fig. 5c and g as Pearson coefficients which are expressed
as averages ± standard deviation.
mCherry-GFP-LC3B autophagic flux assay and image J
macro analysis

The 769-P cells stably expressing mCherry-GFP-LC3B
(retroviral pool 1 and 2) were seeded at 250,000 cells/
well on glass coverslips. Cells were transfected with control MIR and MIR494, following overnight adherence
and at ninety-six hours post-transfection, cells were
fixed, blocked, and coverslips mounted on glass slides
with DAPI mounting media.
Analysis of autophagic flux was performed using
Image J (http://imagejdocu.tudor.lu/doku.php?id=plugin:analysis:colocalization_analysis_macro_for_red_and_green_puncta:start). Briefly, a total of 10 pictures were
captured for each sample (120 pictures) using a Perkin
Elmer Confocal Spinning Disc Microscope (CMMB Core
Facility, University of South Florida, Tampa, Florida)
followed by Image J Macro analysis for each of the

Page 4 of 14

images captured. This program was used to quantify the
green, red, and merged (yellow) punctae.
Transmission Electron Microscopy (TEM) for
ultrastructural analysis

Duplicate 100 mm dishes of 769-P cells expressing control or MIR494 were submitted for transmission electron
microscopy. The cells were fixed in situ with 2.5 % phosphate buffered glutaraldehyde, post-fixed with 1 % osmium tetroxide, scraped from the dishes, the duplicate
dishes were pooled, and the cells were pelleted by centrifugation and embedded in 3 % agarose. Blocks were produced from the agarose of control and treated cells,
which were dehydrated in a graded series of acetone dilutions, cleared in propylene oxide and embedded in LX
112 epoxy resin (Ladd Research Industries, Williston,
VT). Following polymerization, ultrathin sections of the
samples were obtained, stained with 8 % uranyl acetate
and Reynold’s lead citrate, examined and photographed
on an FEI Morgagni TEM (FEI, Hillsboro, OR) at 60 kV.
LipidTOX neutral lipid staining

769-P cells were seeded at 250,000 cells/well. Following
overnight attachment, cells were transfected with control
MIR or MIR494 as described above. Twenty-four hours
post-transfection, cells were trypsinized and re-seeded
on glass coverslips at 150,000 cells/well. When experiments required co-transfection of siRNA and miRNA,
250,000 cells were re-seeded after the co-transfection was
completed and processed at 72 h post-mimic transfection.
Ninety-six hours post-transfection, cells were fixed using
4 % formaldehyde for 30 min at room temperature,
followed by a PBS wash and LipidTOX green neutral lipid
staining (#H34475, Life Technologies) at a 1:200 dilution
in PBS for 1 h. Coverslips were mounted on glass slides
along with DAPI mounting media. Imaging was carried
out using a Perkin Elmer Confocal Spinning Disc Microscope (CMMB Core Facility, University of South Florida,
Tampa, Florida).
Cholesterol measurements

Cell protein lysates were collected and normalized as described above. The Amplex red cholesterol assay kit
(#A12216, Life Technologies) was used to measure total
cholesterol content. The samples were diluted in 1X
reaction buffer provided with the kit at a 2:3 ratio. Fluorescence measurements were captured on a Biotek plate
reader.
LC3B 3′-UTR and promoter luciferase assays

T80 cells were seeded at 250,000 cells/well. Following
overnight adherence, cells were transfected using
Fugene HD with 1 μg of pEZX-MT01 plasmid harboring 3′-UTR of LC3B downstream of firefly luciferase
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(LC3B, HmiT019948-MT01) and 200 pmol of control
or MIR494. Twenty-four hours post-transfection, cells
were washed in PBS and then the assay was performed
following the manufacturer’s instructions (#LPFRM010, GeneCopoeia, Rockville, MD).
T80 cells were seeded at 250,000 cells in 6-well plates.
Following overnight attachment, cells were transfected
using Fugene HD with 1 μg of pLightSwitch promoter
plasmid (Switchgear Genomics, Carlsbad, CA) harboring
the LC3B promoter upstream of RenSP (#32031) with
200 pmol of control or MIR494. Twenty-four hours
post-transfection, cells were washed in PBS and then the
assay was conducted following the manufacturer’s instructions for the pLightSwitch Luciferase Assay system.
Statistical analyses

The number of independent replicates are as specified in
the Figure Legends. Error bars represent standard deviations and p-values (generated using Graphpad Prism
software) were derived by performing the standard student’s t-test (**** = p ≤ 0.0001, *** = p ≤ 0.001, ** = p ≤
0.01, * = p ≤ 0.05 and ns = not significant (p > 0.05)).

Results
MIR494 modulates cell viability by altering the apoptotic
response and LC3B levels

To assess the functional changes elicited by MIR494 expression in 769-P cells, we initially examined changes in
cellular morphology via light microscopy ninety-six
hours post MIR494 transfection. As shown in Fig. 1a, we
observed a reduction in cell density and large cytoplasmic vacuoles in 769-P cells expressing MIR494. We
assessed cellular viability (Fig. 1c) and quantified the
miRNA level of MIR494 following expression (Fig. 1b).
As shown in Fig. 1d, MIR494 expression induced an increase in late apoptotic cells in the 769-P cell line.
These changes in apoptotic response were validated
via western analysis by assessing PARP cleavage (an
apoptotic marker) which increased in MIR494 expressing cells. In addition, we assessed LC3B expression, a
marker of the autophagic pathway which regulates cell
survival responses, which also markedly increased
(Fig. 2a). To ensure that the MIR494-mediated effect on
cleaved PARP and LC3B were specific to the miRNA, we
first tested the effect of an antagomir targeting MIR494
in 769-P cells. Following ninety-six hours of MIR494 expression in the presence or absence of anti-MIR494, we
noted that addition of antagomir to MIR494 expressing
cells increased cell density compared to cells only expressing MIR494 (Fig. 2b). Indeed, cells treated with
anti-MIR494 had a marked reduction in cleaved PARP
(Fig. 2a). In addition, we noted that the LC3B levels reduced to baseline levels in the presence of anti-MIR494
compared to MIR494 expressing cells (Fig. 2a). In addition,
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we performed knockdown of Argonaute 2 (Ago2), a protein
involved in the formation of the RISC (RNA-induced silencing complex) complex essential for binding to target
mRNA, in the absence or presence of MIR494. As shown
in Fig. 2c and d, with >80 % reduction in Ago2 protein, reduction of Ago2 in cells expressing MIR494 increased cell
density compared to cells with wild type Ago2 expression
in the presence of MIR494 (Fig. 2c). Western blot analyses
showed a marked reduction in cleaved PARP and LC3B
levels compared to cells expressing MIR494 with wild type
Ago2 levels.
To further define the apoptotic pathway induced by
MIR494 in 769-P cells, we assessed caspase- and AIFdependency. Via western analyses, we examined the activation status of both initiator and executioner caspases
in the absence or presence of MIR494 expression. In
contrast to T80 cells (a normal immortalized ovarian cell
line) [23] treated with increasing doses of arsenic trioxide (As2O3) which showed a marked reduction in expression of pro-caspase 2, 3, 8, and 9 with increasing
doses of As2O3 (our previous findings support these results [21]), 769-P cells expressing MIR494 did not elicit
any reproducible changes in expression of the procaspases assessed (Fig. 3a). Since AIF is reported to be
involved in caspase-independent apoptosis by translocating from the mitochondria to the nucleus to induce
DNA fragmentation [24], we performed immunofluorescence staining for AIF in 769-P cells expressing MIR494.
Based on COXIV immunostaining (a mitochondrial
marker) (Fig. 3c) in parental 769-P cells, it would appear
that AIF remains associated with the mitochondria
under baseline conditions. As shown in Fig. 3b, we did
not observe nuclear localization of AIF upon MIR494
expression at 96 h post-transfection (or in T80 cells
treated with cisplatin (results not shown)). Collectively,
these findings suggest that MIR494 mediates an apoptotic response that does not involve activation of caspase
2, 3, 8, or, 9 or localization of AIF to the nuclear
compartment.
As shown in Fig. 3d, there was a marked increase in
both the size and number of LC3B endogenous punctae
with MIR494 expression in the absence of changes in autophagic flux (results not shown). We noted 2 imperfect
MIR494 binding sites in the 3′-UTR of LC3B (Fig. 3e).
To assess whether MIR494 alters the LC3B RNA transcript level, we performed real-time PCR analysis using
RNA isolated from MIR494 expressing cells and determined that LC3B RNA was increased (1.39-fold; 28 %
increase) upon MIR494 expression relative to control
cells (Fig. 3f ). Next, to assess whether LC3B could be a
target of MIR494, we performed a 3′-UTR luciferase
assay. As shown in Fig. 3g, expression of MIR494 increased (1.33-fold; 25 % increase) luciferase activity in
cells transfected with a plasmid containing the 3′-UTR of

Dutta et al. BMC Cancer (2016) 16:33

A

Page 6 of 14

B

Control MIR

769-P

Median CT
=38.58

MIR494

Median CT
=38.34

RNA-Fold Change

800

600

400

200

0

Control MIR

C

D

MIR494

769-P

****

Cell Viability

3

2

1

0

Control MIR

MIR494

Fig. 1 MIR494 modulates cell viability by altering the apoptotic response and LC3B levels. a Light microscope images of 769-P cells expressing
MIR494 or control MIR were captured 96 h post-transfection. Representative images at 40× magnification are presented. b miRNA isolation and
quantification of MIR494 was performed in 769-P cells expressing control or MIR494. Cycle threshold changes (left panel) and RNA-fold changes
(right panel) are presented. Three independent experiments were performed. c 769-P cells expressing MIR494 or control MIR were re-seeded into
96-well plates; following 96 h post-transfection, cell viability was assessed. A total of five independent replicates were performed. d Annexin V-PI
staining was performed in 769-P cells expressing MIR494 or control MIR at 96 h post-transfection. Raw data plots are shown as log fluorescence
values of annexin V-FITC and PI on the X and Y axis, respectively. The percentage of viable, early apoptotic, and late apoptotic cells are shown.
Three independent replicates were performed

LC3B. Since miRNAs have recently been implicated in increasing RNA transcript levels via binding to gene promoter elements, MIR494 could therefore be mediating its
effect via the promoter of LC3B. Therefore, we assessed
whether MIR494 could modulate LC3B promoter activity.
As shown in Fig. 3h, we noted that expression of MIR494
increased LC3B promoter activity 2.01-fold (50 % increase). These results suggest that LC3B may be a downstream target of MIR494. Additionally, since LC3B is
involved in autophagy, we also investigated whether
MIR494 led to any change in autophagic flux. However,
we did not identify autophagic flux changes with MIR494
expression in 769-P cells (results not shown).

Increased lipid droplets in MIR494-expressing cells

Since it has been reported that the apoptotic response is
associated with the formation of lipid droplets [4], we next
performed transmission electron microscopy (TEM) to
identify ultrastructural changes including the formation of
lipid droplets in MIR494 expressing cells. As shown in
Fig. 4a, we noted a marked increase in the numbers of
lipid droplets, cholesterol clefts, and multilamellar bodies
in MIR494 expressing cells.
To validate these changes observed by TEM, we measured total cellular cholesterol levels. However, in contrast
to the TEM which showed increased cholesterol clefts,
MIR494 expression was found to reduce total cellular
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Fig. 2 Validation of MIR494 cellular responses. a 769-P cells were seeded at 50,000 cells/well in a 24-well plate. Twenty-four hours post-seeding,
cells were transfected with control mimic, MIR494 mimic, control antagomir, MIR494 antagomir in combination as indicated. Ninety-six hours
post-transfection, protein lysates were collected, samples run on a SDS-PAGE gel, and analyzed via western blotting using the indicated
antibodies. Three independent experiments were performed. b Representative light micrograph images are shown. c Representative light
micrographs of 769-P cells treated with Ago2 siRNA and expressing MIR494 or control MIR are presented. d Protein lysates isolated from 769-P
cells treated with Ago2 siRNA and expressing MIR494 or control MIR were analyzed by western blotting using the indicated antibodies. Three
independent experiments were performed
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(See figure on previous page.)
Fig. 3 MIR494 induces LC3B mRNA expression and LC3B-associated punctae. a T80 cells were seeded at 250,000 cells/well. Twenty-four hours
post-seeding, cells were treated with the indicated doses of As2O3 for 18 h, after which protein lysates were collected. Samples were run on a
SDS-PAGE gel and analyzed via western blotting using the indicated antibodies. Two independent experiments were performed. b Indirect
immunofluorescence was performed on 769-P cells transfected with MIR494 or control MIR at 96 h post-transfection for AIF. Three independent
experiments were performed. Representative images are presented. c Indirect immunofluorescence was performed on 769-P cells for AIF or COXIV.
Representative images are presented. d 769-P cells expressing MIR494 were subjected to immunofluorescence staining for LC3B. Two independent
experiments were performed. Representative images are presented. e The schematic depicts MIR494 binding sites in the 3′-UTR of LC3B (2 imperfect
binding sites). Grey boxes indicate the binding region on the mRNA transcript of LC3B. f Total RNA was isolated from 769-P cells expressing MIR494 or
control MIR and used for real-time PCR. Relative RNA-fold changes are presented for LC3B. Three independent experiments were performed. g T80 cells
were transfected with pEZX-MT01 plasmid harboring the 3′-UTR of LC3B downstream of the luciferase gene in the absence or presence of MIR494.
Three independent experiments were performed. h T80 cells were transfected with pLightSwitch plasmid harboring the promoter of LC3B upstream of
the luciferase gene in the absence or presence of MIR494. Three independent experiments were performed

cholesterol levels compared to control cells (Fig. 4b). This
response is similar to that reported for chemotherapeutic agents that deplete intracellular cholesterol
which sensitizes cancer cells to cell death [25]. We
then utilized LipidTOX immunofluorescence stain to
validate whether MIR494 alters lipid droplet numbers and/or size. As shown in Fig. 4c and d, we observed a marked increase in lipid droplets upon
MIR494 expression. Since LC3B and ATG7 are associated with the outer surface of lipid droplets [26]
and deletion of ATG7 in a mouse model promotes
lipid accumulation [27], we next assessed whether
these two molecules may contribute to MIR494-mediated formation of lipid droplets. Thus, we performed siRNA-mediated knockdown of LC3B and
ATG7 in the absence or presence of MIR494 expression. By western analyses, we noted a marked reduction in LC3B levels with siRNA targeting LC3B
while ATG7 knockdown markedly altered the ratio
of LC3-I/II (Fig. 4e). LipidTOX neutral lipid staining in cells transfected with control, LC3B, or ATG7
siRNA in the absence or presence of MIR494 expression is shown in Fig. 4f and g. Knockdown of
ATG7 alone led to an increase in the number of
lipid droplets which was further increased upon expression of MIR494. Compared to control siRNA in
the presence of MIR494, LC3B siRNA with MIR494
expression significantly reduced the numbers of
lipid droplets. These results indicate that LC3B contributes to MIR494-mediated increase in lipid droplet formation while this process is independent of
ATG7. With MIR494 expression, we also noted an
increase in cleaved PARP in control, LC3B, and
ATG7 siRNA treated cells. However, via annexin V/
PI staining, we did not identify any large changes
in dead cells upon MIR494 expression with LC3B
or ATG7 knockdown, compared to control siRNA
(Fig. 4h). This result suggests that LC3B or ATG7
only contribute a small aspect of the MIR494 apoptotic response.

Mitochondrial changes are observed with MIR494
expression

Since mitochondria undergo dramatic structural changes
during the apoptotic response and are also involved in
the uptake of fatty acids from lipid droplets [28], we next
assessed mitochondrial changes upon MIR494 expression
in 769-P cells. By TEM analyses, we noted an electron
dense region in the mitochondria of MIR494 expressing
cells relative to control cells (Fig. 5a). To investigate the
nature of these mitochondrial changes, we performed immunofluorescence staining with cytochrome c. Since
mitochondria undergo dynamic morphological changes,
we segregated the structural patterns of cytochrome c into
four categories: (1) tubular elongated, (2) tubular shortened, (3) tubular shortened fragmented, and (4) fragmented mitochondria. We captured images of control and
MIR494 expressing cells and classified the cytochrome c
mitochondrial staining pattern into these four categories.
In MIR494 expressing cells, we observed a marked
increase in category 3 and 4 mitochondrial patterns
(fragmented mitochondria). Furthermore, by assessing
endogenous LC3B co-localization with cytochrome c
via immunofluorescence staining, we determined that
there was increased LC3B co-localization to category 3
and 4 fragmented mitochondria (Fig. 5b and c (Pearson
coefficients)). These results suggest that MIR494 expression may alter mitochondrial structures which are
associated with LC3B punctae.
Proteins involved in mitochondrial dynamics include
PTEN-induced putative kinase 1 (PINK1, involved in
phosphorylation and recruitment of Parkin to
mitochondria during mitophagy) [29] and Dynaminrelated protein 1 (Drp1, involved in mitochondrial fission events) [30]. Since we observed that MIR494 expression increased mitochondrial fragmentation [31],
we next assessed changes in protein expression of
PINK1 or Drp1 by western analyses. As shown in
Fig. 5d, we observed a decrease in PINK1 levels in the
absence of changes in Drp1 protein in MIR494 expressing cells. Since reduction of PINK1 protein leads
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Fig. 4 MIR494 increases lipid droplets in an LC3B-dependent and ATG7-independent manner. a TEM images captured from MIR494 or control MIR
transfected 769-P cells. Yellow arrowheads indicate lipid droplets, green arrowheads indicate cholesterol clefts, blue arrowheads indicate multilamellar
bodies, and dark blue arrowheads indicate lipid whorls (autophagosomes). b 769-P cells expressing MIR494 or control MIR were utilized for cholesterol
measurements ninety-six hours post-transfection. Three independent experiments were performed. c 769-P cells expressing MIR494 or control MIR
were re-seeded at 150,000 cells/well on glass coverslips. Ninety-six hours post-transfection, cells were fixed and stained with green neutral lipid stain.
Representative images from three independent experiments are presented. d Graphical quantification of the data obtained from (c). e Protein lysates
isolated from 769-P cells treated with LC3B or ATG7 siRNA in the absence or presence of MIR494 or control MIR were analyzed by western blotting using
the indicated antibodies. Three independent experiments were performed. f 769-P cells treated with LC3B or ATG7 siRNA were re-seeded at 250,000 cells/
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respectively. The percentage of viable and dead cells are shown. Three independent experiments were performed
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to mitochondrial fission in a Drp1-dependent manner
[29], we then assessed whether Drp1 localization was altered with MIR494 expression. As shown in Fig. 5e and f
(Pearson coefficients), co-localization of Drp1 with cytochrome c was increased in MIR494 expressing cells.

Additionally, since PINK1 loss is reported to increase oxidative stress and thus mitochondrial fission [29], we then
assessed superoxide levels using MitoSOX in MIR494 expressing cells. However, we did not identify any significant
or reproducible changes in superoxide levels in MIR494
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expressing cells compared to control cells (results not
shown). Collectively, these results suggest that the mitochondrial fragmentation observed with MIR494 expression may be due to reduction in PINK1 protein and Drp1
recruitment to mitochondria.

Discussion
Herein, we now demonstrate that MIR494 leads to a
marked reduction in cell growth in 769-P renal cancer
cells which is associated with lipid droplets, reduced
total cholesterol levels, and mitochondrial changes. The
reduction in cell viability induced by MIR494 has been
observed in other cancer types; indeed, several MIR494
targets have been thus far identified which are associated with reduced cellular survival including IGF2 [17],
c-KIT [20], HOXA10 [32], CLPTM1L [33], SCGN [34],
CXCR4 [35], and c-myc [36]. As schematically depicted
in Fig. 6, we observed that MIR494 expression increased lipid droplets in a LC3B–dependent manner.
Further, knockdown of ATG7 increased the number of
lipid droplets in a MIR494-independent manner. Altered
mitochondrial patterns and increased LC3B-punctae
size were also observed in MIR494 expressing cells. The
effects of MIR494 were shown to be mediated in an
Ago2-dependent mechanism and could also be reversed
through the use of antagomirs. However, since Ago2 is
an important mediator in miRNA biogenesis pathway,
it is likely to affect the expression of multiple other

Fig. 6 Model of MIR494 cellular responses in 769-P cells. MIR494
induces increase in cleaved PARP and LC3B in 769-P cells. This
response was Ago2-dependent and was reversed upon addition of
anti-MIR494. MIR494 expression led to reduction in total cholesterol
levels, mitochondrial changes, LC3B punctae changes, and a significant
increase in lipid droplets. The increase in lipid droplets observed in
MIR494 expressing cells was dependent on LC3B. ATG7 knockdown led
to an increase in smaller sized lipid droplets which was not altered by
MIR494 expression
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miRNAs. Nonetheless, a similar phenomenon to what
we observed has been reported for other targets such
as RelA which undergoes a miRNA-activation mechanism that is ablated following Ago2 siRNA treatment
[37]. It is interesting that Ago2 is targeted for degradation in the autophagosome via NDP52 and therefore,
the autophagic process appears essential in controlling
the activity of miRNAs [38].
We also demonstrate that LC3B may be a novel downstream target of MIR494. Although we identified that
there was a significant and reproducible increase in LC3B
3′-UTR luciferase activity, the physiological importance of
this observation remains unclear until additional mutational analyses of the 3′-UTR of LC3B to assess whether
LC3B is a direct target of MIR494 is performed. However,
the fold-increase was subtle (although significant and reproducible). In contrast, the LC3B promoter activity was
markedly increased (50 %) by MIR494. This observation is
supported by evidence in the literature describing an RNA
activation mechanism involving promoter-based events
[37, 39] in which the miRNA has target sites in the promoter regions of the DNA. Since LC3B has been reported
to be involved in the formation of lipid droplets [26], it is
interesting that MIR494 expression leads to increased
LC3B mRNA and protein. Transcriptional regulation of
LC3B is reported to be involved in regulating autophagosome size [40, 41]. As indicated earlier, autophagic proteins such as LC3B and ATG7 have roles in lipid droplet
biogenesis [26]. Specifically, the conjugated form of LC3B
(LC3-II) is associated with the outer membrane of lipid
droplets [26]. The conjugation process of LC3B to phosphatidylethanolamine is contributed by the activity of
ATG7, an E1-like activating enzyme; however, LC3B can
also associate with membranes independently of ATG7 in
some systems [42]. Since we observed that knockdown of
ATG7 did not reduce MIR494 induced formation of lipid
droplets, ATG7 may be dispensable for lipid droplet formation under our conditions. In support of our results
that small lipid droplets increased with ATG7 knockdown,
cells isolated from mice with a targeted deletion of ATG7
showed increased lipid droplets [27].
Apoptosis is well-known to be accompanied by mitochondrial fragmentation [43]. Indeed, our findings also
demonstrate changes in mitochondrial structures. Our
observation of reduced PINK1 protein and altered subcellular distribution of Drp1 in MIR494 expressing cells
is similar to a prior report where elevated oxidative
stress leads to loss of PINK1 which enhances Drp1 recruitment to mitochondria thus augmenting mitochondrial fission [29, 30]. Interestingly, PINK1 is regulated
by PTEN [44] which is a reported target of MIR494
[45–49]; in this regard, it is possible that down-regulation
of PTEN may result in the observed reduction in PINK1
protein.
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Since we noted increased localization LC3B to disorganized mitochondria, it may be possible that MIR494 may
lead to changes in the mitophagy pathway although
more evidence is required. Indeed, prior findings have
implicated PINK1 (as well as Parkin) in modulating selective autophagy of mitochondria [50]. Strikingly, recent
evidence indicates that mitochondrial structural deformities can alter the intracellular movement of fatty acids
[4, 28]. Under conditions of starvation, fatty acids enter
the mitochondrial compartment for β-oxidation; however, decreased mitochondrial fusion events may oppose
this process promoting fatty acid movement to the lipid
droplets, thereby leading to an accumulation of lipid
droplets in the cell [28]. Therefore, our observation of
only subtle changes in cellular survival following LC3B
siRNA treatment suggests that the formation of lipid
droplets may be downstream of the apoptotic/mitochondrial changes. Further experiments need to be conducted
to determine whether there is any alteration in mitochondrial β-oxidation or movement of fatty acids from
mitochondria to lipid droplets.
Although we identified cholesterol clefts via TEMs in
MIR494 expressing cells which were similar to that reported in atherosclerosis [51], we observed a significant
reduction in total cellular cholesterol content upon
MIR494 expression. Since cholesterol disrupting agents
such as lovastatin increases cell death [52], a reduction
in cholesterol levels induced by MIR494 expression
supports the observation that MIR494 reduced cellular
viability with an increase in the apoptotic response. A
few miRNA target genes have thus far been shown to
regulate lipid metabolism; these miRNAs include
MIR33, MIR122, MIR378, and MIR125 [53]. Since
MIR494 expression leads to increased lipid droplets, it
may be possible that MIR494 directly target genes involved in the lipid biogenesis pathway.

Conclusions
Our findings reported herein demonstrate that MIR494
expression leads to reduced cellular viability in 769-P
renal cancer cells. MIR494 alters cellular survival by increasing apoptosis associated with mitochondrial changes,
reduced cholesterol levels, and increased lipid droplet formation in an LC3B-dependent manner.
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